2017 US Politics - Trump's Disapproval Number (43%) is Higher than his Approval Number (35%) (June 28)
In the latest Reuters/Ipsos Core Political, President Trump’s approval number remains low, now at 35%.
Despite the advent of targeted therapies and the associated rise in the use of companion and complementary diagnostics, we are only just emerging from the initial exploratory stages of oncology biomarker testing. As will be argued in this paper, we are on the cusp of a much more radical revolution, and the molecular diagnostics landscape is set to change dramatically in the coming decades. It is crucial that any company entering this space prepare for this imminent upheaval and plan their launch strategy accordingly.
With care for older people rising up the policy agenda and generating widespread debate, we invite you to come on July 20 and hear the findings of our research project exploring unmet need for adult social care for older people and discuss the implications with our panel.
Volunteering for the disadvantaged children.
In an era where politics often overtakes the best cared-for brands, how do responsible stewards prepare their organisations to navigate ideological consumers?
In the latest Reuters/Ipsos Core Political, President Trump is again facing an up-tick in his disapproval numbers.
Welcome to the June edition of Ipsos Update – our monthly round-up of research and thinking from Ipsos’ teams around the world.
2017 US Politics - Trump and Congress Continue to Suffer in Domestically Focused Approval Ratings (May 31)
In the latest Reuters/Ipsos Core Political, healthcare and terrorism are top priorities for Americans.
On the heels of African Youth in 2016, Ipsos is publishing an unprecedented study of African women* to mark the second year of its annual Africa conference at the Dapper Museum. Conducted in seven African countries, the study paints a picture of motivated, independent and optimistic women who are a driving force in this rapidly developing continent.
In the latest Reuters/Ipsos Core Political, concerns over healthcare remain high.